Cetirizine Dosing and Administration Guidelines

Age-Specific Dosing Recommendations

The American Academy of Otolaryngology-Head and Neck Surgery recommends a dose of 10 mg once daily for adults and children 6 years and older with allergic rhinitis and urticaria 1, 2
For children 2-5 years, the recommended dose is 5 mg once daily 1, 2

In patients with moderate renal impairment, the dose should be reduced by 50% to 5 mg daily, according to the British Journal of Dermatology 3
In patients with severe renal impairment, cetirizine should be avoided, as recommended by the British Journal of Dermatology 3

Common side effects of cetirizine include possible sedation, especially at higher than recommended doses, with somnolence rates generally low (0.4-3%) at recommended doses 1, 2, 4
Other potential side effects include headache and dry mouth 2

Cetirizine may cause more sedation than some other second-generation antihistamines, such as fexofenadine, loratadine, and desloratadine, according to the Journal of Allergy and Clinical Immunology 5
For patients concerned about sedation, morning dosing or alternative second-generation antihistamines may be considered, as recommended by the Journal of Allergy and Clinical Immunology 5
Cetirizine is available over-the-counter for adults and children ≥6 years, as stated by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
The British Journal of Dermatology recommends avoiding cetirizine use during pregnancy, especially in the first trimester, if possible 3

Intranasal corticosteroids are generally more effective than oral antihistamines like cetirizine for controlling all symptoms of allergic rhinitis, especially nasal congestion, according to the Journal of Allergy and Clinical Immunology 6, 7
For patients with inadequate response to cetirizine alone, adding intranasal corticosteroids may provide better symptom control, as recommended by the Journal of Allergy and Clinical Immunology 7

The American Academy of Otolaryngology-Head and Neck Surgery recommends oral second-generation antihistamines such as cetirizine at a dose of 5 mg once daily as the first-line treatment for allergic rhinitis in children, with intranasal corticosteroids reserved for cases with inadequate response to antihistamines 8
These medications are particularly effective for symptoms like sneezing, itching, and rhinorrhea, and should be considered when symptoms are inadequately controlled with antihistamines alone 8
The initial assessment should confirm diagnosis based on history and physical examination findings such as clear rhinorrhea, nasal congestion, sneezing, and itchy nose, and assess for associated conditions like asthma, atopic dermatitis, or conjunctivitis 8
If symptoms persist, consider referral for allergy testing to identify specific allergens 8
Immunotherapy is effective for allergic rhinitis, but is typically not considered in very young children due to communication difficulties regarding systemic reactions 9
Regular follow-up is essential to assess treatment response and adjust therapy as needed, and to monitor for potential side effects of medications, particularly sedation with antihistamines 9

The American Academy of Otolaryngology-Head and Neck Surgery states that the combination product azelastine-fluticasone (137 mcg/50 mcg per spray) is explicitly approved only for patients ≥12 years of age for seasonal allergic rhinitis 10
The FDA approval table for intranasal antihistamines documents this age restriction for the combination product azelastine-fluticasone 10

The American Academy of Otolaryngology-Head and Neck Surgery recommends azelastine 0.1% solution (137 mcg per spray) as an acceptable alternative for children aged ≥6 years, with dosing for ages 6-11 years: 1 spray per nostril twice daily 10
Intranasal corticosteroids, such as fluticasone propionate, are the most effective medication class for controlling all symptoms of allergic rhinitis, particularly nasal congestion, according to the American College of Physicians 11

The American Academy of Otolaryngology-Head and Neck Surgery suggests that for inadequate response to monotherapy, clinicians may offer combination pharmacologic therapy using separate devices, such as fluticasone propionate nasal spray plus azelastine nasal spray 12
Combination therapy provides greater symptom reduction than either agent alone in patients ≥12 years, according to the American College of Physicians, though this has not been studied in younger children 11

The American College of Physicians recommends starting with intranasal fluticasone propionate 100 mcg once daily for comprehensive symptom control, and assessing response after 4-7 days 11
Adding azelastine nasal spray (as a separate product) may be considered if symptoms remain uncontrolled, though evidence for this combination in children <12 years is limited, according to the American College of Physicians 11

Common side effects of azelastine include bitter taste, epistaxis, somnolence, and headache, according to the American Academy of Otolaryngology-Head and Neck Surgery 10

The American Academy of Otolaryngology-Head and Neck Surgery and the American Academy of Allergy, Asthma, and Immunology recommend considering immunotherapy (sublingual or subcutaneous) for patients with inadequate response to pharmacotherapy with or without environmental controls 12, 13
Immunotherapy is effective for dust mite and pollen allergies and may prevent development of new allergen sensitizations, according to the American Academy of Allergy, Asthma, and Immunology 13